Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants
- 31 July 2006
- journal article
- Published by Elsevier BV in Antiviral Research
- Vol. 70 (3), 121-131
- https://doi.org/10.1016/j.antiviral.2006.01.012
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concernThe Lancet, 2005
- Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK CellsAntimicrobial Agents and Chemotherapy, 2004
- Evidence for Zanamivir Resistance in an Immunocompromised Child Infected with Influenza B VirusThe Journal of Infectious Diseases, 1998
- The Interaction of Neuraminidase and Hemagglutinin Mutations in Influenza Virus in Resistance to 4-Guanidino-Neu5Ac2enVirology, 1998
- Human influenza A H5N1 virus related to a highly pathogenic avian influenza virusThe Lancet, 1998
- Binding of the Influenza A Virus to Cell-Surface Receptors: Structures of Five Hemagglutinin–Sialyloligosaccharide Complexes Determined by X-Ray CrystallographyVirology, 1997
- Synthesis of polymeric neoglycoconjugates based onN-substituted polyacrylamidesGlycoconjugate Journal, 1993
- A solid-phase enzyme-linked assay for influenza virus receptor-binding activityJournal of Virological Methods, 1992
- Enhancement of activity against influenza viruses by combinations of antiviral agentsAntimicrobial Agents and Chemotherapy, 1980
- Plaque inhibition assay for drug susceptibility testing of influenza virusesAntimicrobial Agents and Chemotherapy, 1980